Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
Letters to the Editor

In Reply: Physician resistance to obesity pharmacotherapy

Yael Mauer, MD, MPH, Marcie Parker, PharmD, BCACP and Sangeeta Kashyap, MD
Cleveland Clinic Journal of Medicine December 2021, 88 (12) 658-659; DOI: https://doi.org/10.3949/ccjm.88c.12004
Yael Mauer
Department of Internal Medicine and Geriatrics, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Find this author on Cleveland Clinic
Marcie Parker
Ambulatory Care Clinical Specialist, Department of Pharmacy, Cleveland Clinic, Beachwood, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sangeeta Kashyap
Professor of Medicine, Cleveland Clinic, Lerner College of Medicine of Case, Western Reserve University; Associate Program Director, Endocrinology, Diabetes, and Metabolism Fellowship, Cleveland Clinic Cleveland, OH Associate Editor,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Find this author on Cleveland Clinic

In Reply: We thank Dr. Modesto-Lowe and colleagues for their comments. We agree that primary care providers need to increase their efforts to diagnose patients with obesity and adiposity-related comorbidities and to discuss with patients the therapeutic options including behavioral, pharmacotherapy, and possibly bariatric surgery. Pharmacotherapy should not be considered a last resort as antiobesity agents are safe and effective and should be offered for patients with a body mass index of 30 kg/m2 or greater and with a body mass index over 27 kg/m2 in the presence of obesity-related comorbidity. Though we also recognize that the cost of antiobesity medications and the lack of insurance coverage for them continue to be major barriers to the regular use of these agents.

In general, primary care doctors need to become more comfortable discussing obesity as a medical problem that requires treatment like all other medical problems.

  • Copyright © 2021 The Cleveland Clinic Foundation. All Rights Reserved.

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2022 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire